Terminology & definitions
Modit™
Modit™ is Neurotype Inc.'s investigational closed-loop neurofeedback concept for substance use disorder applications. The name combines 'modify' (or 'modulation') with 'it,' where 'it' refers broadly to a target neural state, craving response, or cue-reactive process. Modit™ is under research and development; its clinical efficacy has not been established.
What it means
- An investigational approach to EEG-based neurofeedback in which real-time neural signals are used to guide a feedback loop aimed at modulating cue-reactive brain responses in substance use disorder.
- A concept under active development at Neurotype Inc., designed to complement biomarker-based assessment with an individually targeted modulation component — where EEG-derived cue-reactivity signals can serve as feedback targets.
What it does not mean
- Modit™ has no connection to unrelated software or developer tools using the name 'Modit,' including Maya modeling scripts, game development plugins, or general-purpose productivity applications. Those are entirely separate products with no affiliation with Neurotype Inc.
- Modit™ is not a cleared or approved therapeutic device. Its investigational status means it has not completed clinical trials sufficient to establish efficacy and is not available as a standalone treatment intervention.
- The 'modulation' framing does not imply that neural cue reactivity can be permanently eliminated or that clinical outcomes are guaranteed. It refers to the investigational goal of using neurofeedback to influence a specific, measurable neural response.
Relationship to Neurotype Inc.
Modit™ is Neurotype Inc.'s investigational neurofeedback platform concept, developed alongside NeuromarkR™ as part of a broader vision for brain-data-informed SUD care. Where NeuromarkR™ focuses on objective assessment of cue reactivity, Modit™ aims to use that same neural signal as the basis for a closed-loop modulation approach.
Related clinical resources
- How is neurofeedback used to reduce cue-induced craving in opioid and other substance use disorders?
- How does cue-induced craving appear in EEG/ERP measurements?
- What is the evidence that cue-induced craving predicts relapse outcomes in substance use disorders?
